MRNA (MRNA) news: what is happening today

Market summary from our own Hyperliquid data · updated 2026-08-20 04:13 UTC
MRNA trades flat
MRNA has gone nowhere over a week. What follows is what sits behind that move: large-wallet positioning, derivatives, our own model and publisher headlines.
What matters on MRNA right now?
Here is where MRNA actually stands, measured from our own Hyperliquid data. What stands out right now:
- Whale positioning is close to balanced53% of active large-wallet money is positioned long — $4.1 M against $3.6 M across 31 wallets.
- MRNA is mid-range after 2 days61% of the way up a 2-day range that runs $119.350 to $194.990.
- Where the leverage sitsFunding runs at 1.66% a year — longs pay shorts, with $11.4 M of open interest.
What does the MRNA data show?
1. Whale positioning is close to balanced
53% of active large-wallet money on MRNA is positioned long right now: $4.1 M long against $3.6 M short, spread over 31 wallets on Hyperliquid. With the book close to even, whale positioning is not telling you much here — the useful reads are the chart and the derivatives below. These are open positions read from the chain, not opinions, and they change daily.
2. MRNA is mid-range after 2 days
MRNA is 61% of the way up its 2-day range, which runs from $119.350 to $194.990. The same headline number means something different at the top of a range than at the bottom — which is why position is worth naming.
3. Where the leverage sits
Perpetual funding runs at 1.66% annualised, so longs are paying shorts to keep their positions open. Funding is a crowding tax: the more one-sided the book, the more it costs to stay on that side, and the more likely the weakest hands there get squeezed out. Open interest stands at $11.4 M — that is the size of the leveraged book that has to be closed eventually.
How has MRNA been reporting?
Actual earnings against what analysts expected, quarter by quarter; the last 4 came in above the estimate.
- $-1.97 vs $-2.12 expected+7.3%
- $-3.40 vs $-4.04 expected+15.8%
- $-2.11 vs $-2.70 expected+21.7%
- $-0.51 vs $-2.15 expected+76.3%
Reported figures and consensus estimates — Finnhub.
What has already happened to MRNA?
No recorded events for MRNA yet. The algorithm checks the market daily.
What is in the news about MRNA?
Headlines about MRNA from third-party publishers. Each links to the original article; we never claim a headline moved the price — our own read is the measured signal above.
- Why Did MRNA, MRK, TGT Stocks Jump To 52-Week Highs Today?Moderna, Merck and Target stocks soared to annual highs amid positive company catalysts and strong earnings results.
- Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine BreakthroughElon Musk said Wednesday that mRNA technology could fundamentally change how diseases are treated, a shift that would make medicine more of a…
- Dow, S&P 500, Nasdaq Futures Climb As Treasury Yields Pull Back: MRNA, BULL, MSTR, NVAX Stocks In FocusThe U.S. Treasury Department unexpectedly announced Wednesday that it would at least double government debt buybacks, expected to take effect Sept. 9.
- Why this mRNA cancer vaccine is raising new treatment hopeSTORY: :: Why Moderna and Merck's cancer vaccine trial may be a milestone :: New York / August 19, 2026 :: Michele Gershberg, Global Health Editor…
- Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger ExpectationsModerna, Inc. (NASDAQ:MRNA) has delivered a major boost to its turnaround story. Its personalized mRNA cancer vaccine, Intismeran, met the main goal…
- Why Is Moderna (MRNA) Stock Rocketing Higher TodayShares of biotechnology company Moderna (NASDAQ:MRNA) jumped 144% in the afternoon session after its personalized mRNA cancer vaccine, developed with…
Headlines from publisher RSS feeds
What is next for MRNA?
Dates we can verify and levels that would change the read on MRNA. No project roadmaps here — only schedules that exist on-chain or in the company calendar, and thresholds measured from our own data.
Unlock schedule from DefiLlama; earnings dates from the company calendar.
The bottom line
There is not enough history here for a firm verdict. On the last closed day MRNA fell 0.51% against a category median of +0.23%, with 22 of 78 markets in the category closing lower. We do not claim to know why MRNA moved — everything above is measurement, not a cause.
Frequently asked questions
What is the latest news on MRNA?
The most recent development we recorded is: Whale positioning is close to balanced (2026-08-20). This page is a dated log computed from market data rather than a press feed — every entry is a measurement with the date it happened.
How often is the MRNA page updated?
Once a day: it is recomputed after the daily candle closes, and the time of the last update is printed at the top of the page. Log entries are dated by the day the event happened, not the day we published it.
Where does the MRNA data on this page come from?
From Hyperliquid directly: daily candles, open interest, funding and the on-chain positions of active large wallets. Nothing here is copied from another site's article, and no language model writes the text — the wording is generated from the numbers by fixed rules.
Is this MRNA page investment advice?
No. It is an algorithmic summary of measured market data from Hyperliquid — price moves, positioning, derivatives and our own model. It is not investment advice and past performance does not guarantee future results.
Markets like MRNA
Nebius (NBIS)BUY- UN UNITREE (UNITREE)NEUTRAL
Marvell (MRVL)BUY
Intel (INTC)NEUTRAL
Cerebras Systems (CBRS)NEUTRAL
Circle (CRCL)BUY
CASHCAT
HEMI
MET
KORU
HYPE
ACE
GRASS
BOT
CRWD